PE52496A1 - Nueva sulfonamida y procedimiento de obtencion - Google Patents

Nueva sulfonamida y procedimiento de obtencion

Info

Publication number
PE52496A1
PE52496A1 PE1995285176A PE28517695A PE52496A1 PE 52496 A1 PE52496 A1 PE 52496A1 PE 1995285176 A PE1995285176 A PE 1995285176A PE 28517695 A PE28517695 A PE 28517695A PE 52496 A1 PE52496 A1 PE 52496A1
Authority
PE
Peru
Prior art keywords
formula
compound
lower alkyl
halogen
reaction
Prior art date
Application number
PE1995285176A
Other languages
English (en)
Inventor
Loffler Bernd-Michael
Hirth Georges
Ramuz Henri
Cassal Jean-Marie
Neidhart Werner
Muller Marcel
Clozel Martine
Breu Volker
Burri Kaspar
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of PE52496A1 publication Critical patent/PE52496A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Abstract

SE REFIERE A: 1) EL COMPUESTO DE FORMULA I DONDE: R1 ES HETEROCICLILO, DE PREFERENCIA PIRIDILO; R2 ES HIDROGENO, ALQUILO INFERIOR, ALCOXILO INFERIOR ENTRE OTROS, DE PREFERENCIA HIDROGENO; R3 ES ALQUILO INFERIOR, ALCOXILO INFERIOR, -CH2O-A-ALQUILO INFERIOR, -(CH2)m-O-(CRaRb)nOH ENTRE OTROS; DONDE Ra Y Rb SIGNIFICAN H o ALQUILO INFERIOR; A SIGNIFICA UN GRUPO 1,2-DIHIDROXI-ETILENO CETALIZADO; B ES -OC(O)O-, -NH(C(O)NH o -NHC(O)O-; n ES 2, 3, o 4; m ES 0 o 1; R4, R5, R6, R7, R8 SON INDEPENDIENTEMENTE HIDROGENO, ALCOXILO INFERIOR O HALOGENO; R9 ES HETEROCICLILO, FENILO NO SUSTITUIDO O SUSTITUIDO CON ALQUILO INFERIOR, ALCOXILO INFERIOR Y/O HALOGENO ENTRE OTROS; 2) EL COMPUESTO DE FORMULA II DONDE Hal SIGNIFICA HALOGENO; 3) A LOS PROCEDIMIENTO DE OBTENCION TALES COMO: a) REACCION DE UN COMPUESTO DE FORMULA II CON UN COMPUESTO DE FORMULA HO(CRaRb)nXH, DONDE n, Ra Y Rb, YA SE DEFINIERON y X SIGNIFICA O o NH, o; b) REACCION DE UN COMPUESTO DE FORMULA III CON UN COMPUESTO DE FORMULA R1SO2Z, DONDE Y ES HALOGENO Y Z AMINO, o Y REPRESENTA AMINO y Z HALOGENO, o; c) REACCION DE UN COMPUESTO DE FORMULA IV CON UN ISOCIANATO DE FORMULA R9NCO o UN CLORURO DE CARBAMOILO DE FORMULA R9NCOCl, ENTRE OTROS. ESTE COMPUESTO ES USADO EN EL TRATAMIENTO DE ENFERMEDADES ASOCIADAS CON ACTIVIDADES DE LA ENDOTELINA TALES COMO HIPERTENSION E ISQUEMIA
PE1995285176A 1994-11-25 1995-11-21 Nueva sulfonamida y procedimiento de obtencion PE52496A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH355994 1994-11-25

Publications (1)

Publication Number Publication Date
PE52496A1 true PE52496A1 (es) 1996-12-12

Family

ID=4258608

Family Applications (1)

Application Number Title Priority Date Filing Date
PE1995285176A PE52496A1 (es) 1994-11-25 1995-11-21 Nueva sulfonamida y procedimiento de obtencion

Country Status (9)

Country Link
AR (2) AR002251A1 (es)
BR (1) BR9505528A (es)
CO (1) CO4650181A1 (es)
PE (1) PE52496A1 (es)
PL (1) PL185692B1 (es)
TR (1) TR199501486A2 (es)
UY (1) UY24100A1 (es)
WO (1) WO1996016963A1 (es)
ZA (1) ZA959808B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI284642B (en) * 1999-01-18 2007-08-01 Hoffmann La Roche Novel heterocyclic sulfonamides
NZ525614A (en) * 2000-12-18 2005-03-24 Actelion Pharmaceuticals Ltd Novel sulfamides and their use as endothelin receptor antagonists
EP2343282B1 (en) 2004-03-05 2015-07-22 F. Hoffmann-La Roche AG Diaminopyrimidines as P2X3 and P2X2/3 antagonists
AR062501A1 (es) 2006-08-29 2008-11-12 Actelion Pharmaceuticals Ltd Composiciones terapeuticas
MX2010001837A (es) 2007-08-17 2010-03-10 Actelion Pharmaceuticals Ltd Derivados de 4-pirimidinasulfamida.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2086544C1 (ru) * 1991-06-13 1997-08-10 Хоффманн-Ля Рош АГ Бензолсульфонамидные производные пиримидина или их соли, фармацевтическая композиция для лечения заболеваний, связанных с активностью эндотелина

Also Published As

Publication number Publication date
WO1996016963A1 (de) 1996-06-06
BR9505528A (pt) 1997-11-04
CO4650181A1 (es) 1998-09-03
AR002251A1 (es) 1998-03-11
PL185692B1 (pl) 2003-07-31
PL311487A1 (en) 1996-05-27
UY24100A1 (es) 2000-12-29
TR199501486A2 (tr) 1996-07-21
AR010549A2 (es) 2000-06-28
ZA959808B (en) 1996-05-27

Similar Documents

Publication Publication Date Title
PE20030809A1 (es) Derivados de piperidina como antagonistas de la hormona concentradora de la melanina (mch)
PE106499A1 (es) Antagonistas del receptor ccr-3
PE20011047A1 (es) Compuesto de amida y composiciones farmaceuticas para inhibir proteinquinasas
PE20021005A1 (es) Quinazolinas como inhibidores de mmp-13
AR006720A1 (es) Un compuesto derivado de azahexano heterociclico, su uso para la preparacion de una composicion farmaceutica, procedimiento para prepararlo y una composicion farmaceutica que lo comprende
PE115999A1 (es) Secretagogos de la hormona del crecimiento
PE20020061A1 (es) Fenil sulfamoil carboxamidas sustituidas
PE20051039A1 (es) [1,8] naftiridin-2-onas y compuestos relacionados
CO5200785A1 (es) Uso terapeutico de quinazolina
AR042461A1 (es) Analogos 2-sustituidos de quinazolin-4-il - amina. composiciones farmaceuticas
PE20020657A1 (es) Derivados de amida de piperidinas 1,4-disustituidas de formula (i)
EA200300428A1 (ru) Антагонисты метаботропных рецепторов глутамата
AR038341A1 (es) Compuestos que son agonistas de receptores alfa-1 preferentemente agonistas de receptores alfa-1a/l
UY25873A1 (es) Derivados de 3-azabiciclo [3.1.0] hexano útiles en terapia en afecciones mediadas por receptores opiáceos
ATE201867T1 (de) N-aminoalkylfluorencarboxamide, neue klasse von dopaminerezeptor subtype spezifische liganden
PE91798A1 (es) Pirrolicarboxanilidas condensadas: utiles como ligandos receptores
NO972841D0 (no) Aryl- og heteroaryl-sulfonamidderivater, deres fremstilling og anvendelse som endotelinantagonister
PE20040757A1 (es) Derivados de benzoxazina
FI935517A0 (fi) Fenoxi- och fenoxialkylpiperidiner som virusmotverkande medel
PA8575001A1 (es) Fluorobenzamidas como inhibidores de maob
PE14696A1 (es) Derivado de fenetanolamina
AR015964A1 (es) Compuestos de isoquinolina, su uso, procedimiento para tratar una afeccion, procedimiento de preparacion del compuesto, composicion farmaceutica que locontiene y compuesto util en dicho procedimiento
AR042362A1 (es) Derivados de 3h-quinazolin-4-ona, proceso de obtencion y composiciones farmaceuticas que los contienen
PE52496A1 (es) Nueva sulfonamida y procedimiento de obtencion
PE20030705A1 (es) Inhibidores de la 17beta-hidroxiesteroide deshidrogenasa tipo 3 para el tratamiento de enfermedades androgeno-dependientes

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed